Issue and allotment of Fully Convertible Warrants ('Warrants'), to person(s) belonging to the Promoter & Promoter Group Category and Non-Promoter Category, on a preferential basis, aggregating ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Veerhealth Care Ltd, at its meeting on March 28, 2026, approved the issue and allotment of Fully Convertible Warrants on a preferential basis, aggregating up to Rs. 21 crore. The warrants will be issued to 10 proposed allottees — 6 belonging to the Promoter and Promoter Group category and 4 to the Non-Promoter category. Each warrant will carry the right to subscribe to one equity share of Rs. 10 face value, convertible within 18 months from the date of allotment. Allottees will pay 25% of the issue price upfront, with the remaining 75% payable at the time of warrant exercise. The issue price is yet to be determined by the Board in line with SEBI ICDR Regulations, Chapter V. The proposal is subject to shareholder approval through a postal ballot, and a Preferential Issue Committee has been constituted to finalize the relevant documents.
Existing shareholders may see dilution of their equity stake once the warrants are converted into shares over the next 18 months. The strong promoter group participation (over Rs. 11.5 crore of the Rs. 21 crore issue) signals promoter confidence in the business, though it may also consolidate promoter control. The capital raise could strengthen the company's balance sheet if the funds are deployed for growth.